Pharmaceutical Packaging Market worth $251.6 billion by 2034 - Exclusive Report by The Research Insights
CHICAGO, May 13, 2025 /PRNewswire/ -- The global Pharmaceutical Packaging Market is projected to be valued at US$ 139.2 billion in 2024 and reach USD 251.6 billion by 2034, growing at a CAGR of 6.1% according to a new report by The Research Insights. The market for pharmaceutical packaging is driven by the rising demand for adoption of branded and generic medicines in emerging economies across the globe which have propelled the demand for its packaging.
Market Overview and Growth Trajectory:
Pharmaceutical Packaging Market Growth: According to an exhaustive report by The Research Insights, the Pharmaceutical Packaging Market is experiencing significant growth, driven by the increasing focus on environmental sustainability is transforming various industries including the pharmaceutical packaging market. Because consumers along with governmental bodies and healthcare providers prioritize sustainable practices more than ever before they now seek packaging solutions that serve environmental health in addition to their functional purpose. Biodegradable films along with recyclable blister packs and paper-based secondary packaging solutions together with refillable container systems are becoming more popular. The pharmaceutical packaging market valued at US$ 139.2 billion in 2024, is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.1% during 2025–2034.
For More Information and To Stay Updated on The Latest Developments in The Pharmaceutical Packaging Market, Download The Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Escalating the Role of Packaging in Modern Healthcare: The smart healthcare industry's constant evolution has positioned patient safety and drug integrity at the forefront while recognizing packaging as an essential element in fulfilling this mission. The pharmaceutical packaging market adapts to urgent demands for protection against medication contamination, tampering risks and human mistakes. International health authorities and governments have enforced strict regulatory measures aimed at protecting pharmaceutical supply chains. From the U.S. FDA's Drug Supply Chain Security Act to Europe's Falsified Medicines Directive, the message is clear: Product packaging needs to perform beyond containment functions by verifying product authenticity and safeguarding user safety and correct usage. Manufacturers are swiftly incorporating tamper-evident seals together with anti-counterfeit packaging and child-resistant features into their packaging production lines. Healthcare providers demand packaging solutions that reduce risks when medications are dispensed and administered. Accurate dosing blister packs and contamination-reducing prefilled syringes along with real-time product information smart labels are now more prevalent. The pharmaceutical packaging market growth that focuses on security and usability so drugs reach patients safely and maintain effectiveness.
E-commerce Boom Redefines Expectations in the Pharmaceutical Packaging Market: The growth of e-commerce and direct-to-patient healthcare models transforms medicine delivery and creates new requirements for pharmaceutical packaging market. The expanding use of online pharmacies for delivering prescriptions to patients' doorsteps means packaging now functions as an essential component of the healthcare experience. Modern consumers demand identical convenience and security standards for healthcare deliveries compared to their expectations from any online transaction. But pharmaceuticals come with unique challenges: Due to their temperature sensitivity and the need for tamper-proof protection pharmaceuticals must reach their destination intact and punctually. The pharmaceutical packaging market size is rapidly developing to fulfil stringent requirements of the sector. Insulated mailers and smart packaging solutions that monitor temperature in real-time have gained significant popularity because biologics, vaccines, and specialty drugs demand strict temperature control. The pharmaceutical packaging market needs to accelerate innovation at unprecedented rates to adapt to the demands of this new reality.
Stay Updated on The Latest Pharmaceutical Packaging Market Trends: https://www.theresearchinsights.com/request_sample?id=10035
Diverse Drug Delivery Formats Shaping the Future of the Pharmaceutical Packaging Market: Modern therapeutic advances have resulted in various drug delivery formats which create specialized packaging requirements and potential opportunities for pharmaceutical packaging market. The field of ophthalmic drug delivery requires sterile packaging that delivers exact doses through single-use droppers and preservative-free multi-dose systems to protect patients from microbial contamination. Advanced packaging formats like prefilled syringes, vials, and ampoules with tamper-evident seals and temperature-resistant properties maintain drug integrity during storage and transport for injectable and IV drugs used in biologics and oncology treatments. The increasing use of nasal drug delivery for local and systemic treatments, such as vaccines and emergency medications demands the creation of unit-dose or metered-dose spray packaging which supports both easy administration and patient adherence. Effective wound care packaging requires both sterile conditions and easy access which is achieved by medical-grade pouches along with barrier films and reclosable packs for clean repeated usage. The field of pulmonary drug delivery for respiratory conditions is advancing inhaler packaging and dosing systems that guarantee precise administration and enhance patient adherence through innovative designs.
Geographical Insights: The pharmaceutical packaging market is primarily dominated by North America which produces 39% of total global revenue. The region's advanced healthcare infrastructure combined with substantial investments in drug development and the establishment of major pharmaceutical companies drives its market dominance. The European region stands as the second-largest pharmaceutical packaging market with Germany, the United Kingdom, and Italy stand as major contributors to this market due to their solid regulatory systems combined with their strong emphasis on research and development. The Asia-Pacific market stands as the third-largest region in terms of market share which amounts to about 19%. The fast-paced growth of the pharmaceutical industry results from improved healthcare knowledge among populations combined with higher disposable incomes and major investments in pharmaceutical production facilities particularly located in China and India.
Pharmaceutical Packaging Market Segmentation and Geographical Insights:
Based on material, the market is divided into plastic, glass, paper & paperboard, metal and others. The plastic segment held the largest share of the pharmaceutical packaging market in 2024.
Based on packaging format, the market is divided into bottles, vials & ampoules, blister packs, syringes, bags & pouches, sachets & stick packs, cartridges, boxes & cartons and other packaging formats. The bottles segment held the largest share of the pharmaceutical packaging market in 2024.
Based on drug delivery, the market is divided into ophthalmic, injectable, iv drugs, nasal, wound care, pulmonary, oral and others (topical and transdermal treatments). The oral segment accounted for a larger share of the pharmaceutical packaging market in 2024.
Based on end-use, the market is divided into pharma manufacturing, contract packaging, retail pharmacy and institutional pharmacy. The pharma manufacturing segment accounted for a larger share of the pharmaceutical packaging market in 2024.
The pharmaceutical packaging market is segmented into five major regions: North America, Europe, Asia Pacific, Central & South America and Middle East & Africa.
Purchase Premium Copy of Global Pharmaceutical Packaging Market Size and Growth Report (2025-2034) at: https://www.theresearchinsights.com/license?id=10035
Key Players and Competitive Landscape:
The Pharmaceutical Packaging Market is characterized by the presence of several major players, including:
Gerresheimer AG
Schott AG
Owens Illinois, Inc.
Amcor plc
Becton, Dickinson, and Company
AptarGroup, Inc.
West Pharmaceutical Services, Inc.
Ardagh Group S.A.
Smurfit WestRock
Comar, LLC
CCL Industries, Inc.
Vetter Pharma International
SGD Pharma
Bormioli Pharma S.p.A.
Klöckner Pentaplast
These companies are adopting strategies such as new product launches, joint ventures, and geographical expansion to maintain their competitive edge in the market.
For Region-Specific Market Data, Check Out Brief Sample Pages: https://www.theresearchinsights.com/request_sample?id=10035
Pharmaceutical Packaging Market Recent Developments and Innovations:
In April 2025, Gerresheimer AG collaborated with Injecto and launched their silicone-oil- and PFAS-free syringe systems which are made from glass and cyclic olefin polymer (COP). PFAS-free syringe systems can be used for ophthalmic applications and sensitive biologics.
In January 2025, Schott AG launched next generation polymer syringe system which provides tamper evidence at individual syringe level. The integrated label concept, developed with Schreiner MediPharm, offers reliable first-opening indication, oxygen and light protection, and can include an RFID chip for accurate drug traceability and inventory management.
In October 2024, Bormioli Pharma S.p.A. partners with Chiesi Group for providing their first pharma primary packaging in carbon capture PET bottles. Carbon Capture PET bottles provide a 21.9% decrease in kg of CO2 eq compared to traditional PET.
Conclusion:
The pharmaceutical packaging market size is experiencing major changes as global healthcare trends and regulatory pressures combine with growing complexity in drug formulations. The rising popularity of e-commerce and direct-to-patient models together with biologics development requires packaging solutions that maintain safety standards while providing temperature management and supply chain traceability. The movement toward sustainable packaging solutions that support global circular economy objectives drives research into biodegradable, recyclable and refillable materials development. The variety of drug delivery methods including injectables and IV medications together with pulmonary and nasal routes leads to a need for specialized packaging solutions to match different dosage types. The pharmaceutical industry prioritizes patient safety and compliance which leads to the adoption of smart labels, prefilled devices and child-resistant technologies as standard features.
Need A Diverse Region or Sector? Customize Research to Suit Your Requirement: https://www.theresearchinsights.com/Ask_For_Customization?id=10035
The report from The Research Insights, therefore, provides several stakeholders—including raw material suppliers, contract pharma manufacturers, and end users —with valuable insights into how to successfully navigate this evolving market landscape and unlock new opportunities.
With projected growth to US$ 251.6 billion by 2034, the Pharmaceutical Packaging Market represents a significant opportunity for raw material suppliers, packaging convertors, end-users, investors, industry stakeholders, and others. By staying abreast of market trends, embracing innovation, and focusing on quality and performance, companies can position themselves for success in this dynamic and evolving market landscape.
Related Report Titles:
Pharmaceutical Packaging Equipment Market Size, Share & Trends Analysis Report
Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report
Pharmaceutical Contract Manufacturing And Research Services Market Size, Share & Trends
Vials And Ampoules Market Size, Share & Trends Analysis Report
Small Volume Parenteral Market Size, Share & Trends Analysis Report
About Us:
The Research Insights provides thoroughly conducted research which is backed up by real-time statistics and data. Our experts are eager to help you with any information required under the sun. The key to our success is keeping abreast with the markets, industries, and ever-changing consumer trends that matter. Our market research professionals have in-depth knowledge and expertise across various domains that includes IT and Telecom, Emerging Technologies, Consumer Offerings, Manufacturing and Others. We are committed to reviewing the scope and procedure of the research studies that you select and provide you with an accurate guidance in order to assist you in taking the correct business decisions.
Contact Us:If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Kaushik RoyE-mail: sales@theresearchinsights.comPhone: +1 312-313-8080Website: https://www.theresearchinsights.com/
Logo: https://mma.prnewswire.com/media/2684869/The_Research_Insights_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/pharmaceutical-packaging-market-worth-251-6-billion-by-2034---exclusive-report-by-the-research-insights-302453600.html
SOURCE The Research Insights
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
28 minutes ago
- Yahoo
Epson's New PowerLite L-Series Portable Projectors Now Available and Compatible with Apple AirPlay
10 New Fixed Lens Projector Models with up to 8,000 Lumens Allow for Easy Sharing of Content from Apple Devices ORLANDO, Fla., June 11, 2025 /PRNewswire/ -- (InfoComm, Epson booth #3427) -- As schools and businesses place greater emphasis on flexibility, collaboration and visual impact, demand is rising for intuitive, high-quality display solutions that support BYOD and multi-platform streaming. Epson, the number one selling projector brand worldwide,1 today announced its newest 3-chip 3LCD PowerLite® L-Series laser projectors are now available and are compatible with Apple® AirPlay®. This enhancement addresses the growing demand for effortless content streaming on large, vibrant displays in education and corporate settings, allowing users to share videos, photos, music, and more from Apple devices directly to their projector. The new lineup delivers higher brightness and pro level features in a portable design, with an expanded range of throw ratios that solve placement challenges. With standard throw projectors and newly added optical zoom on two short throw options, the PowerLite L-Series now covers an expansive range of throw ratios between .5 to 2.2. This allows greater installation flexibility across applications, from floor and rear projection to meeting rooms and lecture halls. "The new PowerLite L-Series models are a unique combination of compact form factor and professional-level features," said Chris Teguh, product manager, large venue projectors, Epson America, Inc. "The addition of Apple AirPlay combability demonstrates our commitment to enhancing user experiences and connectivity to allow users to easily share content in classroom and business settings." Apple AirPlay compatibility allows users to stream movies, music, games, and photos directly to the new PowerLite L-Series projectors from iPhones, iPads or Macs. Users can watch movies and shows from favorite apps or Safari, share photos with everyone in a room, or play music and podcasts on the projector and other AirPlay speakers. Powered by Epson's 3-chip 3LCD technology, the lineup ranges from 6,000- to 8,000-lumens,2 with options featuring Full HD WUXGA resolution and 4K Enhancement Technology3 for sharp, detailed images – even for up close viewing. Built for a variety of environments – classrooms and lecture halls, conference rooms, hybrid workspaces and more – these powerful projectors produce exceptionally vibrant, high-resolution images up to 500 inches in 16:10. Plus, they are capable of projecting in a variety of other aspect ratios, including ultra-wide 16:6 and 21:9 for enhanced content display and visibility. Previously only available in Epson's interchangeable lens lineup, the new projectors include robust installation tools such as NFC,4 advanced geometric correction and the optional PixAlign® camera for simplifying complex multi-projector installations such as screen matching, blending or stacking. They also offer powerful features, such as optical zoom, wide lens shift, geometric correction tools, and more for simple and seamless installation. With built-in wireless communication, users can monitor and control projector fleets remotely from a web browser using the Epson Projector Management Connected app, as well as enable advanced screen casting tools like Apple AirPlay, Epson iProjection™5 and Miracast®.5 "Customers are looking for more accessible ways to build complex multi-projector systems, and these latest PowerLite L models enable that. And now with AirPlay compatibility, they deliver stunning visuals while integrating into today's smart ecosystems," said Teguh. AvailabilityAll new PowerLite L-Series models are now available through authorized Epson with built-in Apple AirPlay 2 compatibility include the PowerLite L690U, L790U, L890U, L690E, L890E, L895E, L690SU, L695SU, L790SE, and L795SE. The PowerLite L690SE and L695SE are available without AirPlay functionality. For existing compatible models, Apple AirPlay 2 is available via a firmware update on Epson's website and will be preinstalled on future models. Special education pricing is available through the Brighter Futures® program. A unique sales and support initiative available specifically for schools, Brighter Futures is designed to help educators select and implement the best products for their classrooms while making the most of their budgets. In addition to special pricing, Brighter Futures offers dedicated education account managers and toll-free technical support for all Epson projectors and associated accessories. For additional information on Epson large venue solutions, visit About EpsonEpson is a global technology leader whose philosophy of efficient, compact and precise innovation enriches lives and helps create a better world. The company is focused on solving societal issues through innovations in home and office printing, commercial and industrial printing, manufacturing, visual and lifestyle. Epson's goal is to become carbon negative and eliminate use of exhaustible underground resources such as oil and metal by 2050. Led by the Japan-based Seiko Epson Corporation, the worldwide Epson Group generates annual sales of more than JPY 1 trillion. Epson America, Inc., based in Los Alamitos, Calif., is Epson's regional headquarters for the U.S., Canada, and Latin America. To learn more about Epson, please visit: You may also connect with Epson America on Facebook ( X ( YouTube ( and Instagram ( 1 Epson is the #1 projector brand worldwide and in the U.S. according to most recent quarterly data from PMA, a leading high-tech market research and publishing firm specializing in the display market.2 Color brightness (color light output) and white brightness (white light output) will vary depending on usage conditions. Color light output measured in accordance with IDMS 15.4; white light output measured in accordance with ISO 21118.3 4K Enhancement Technology shifts each pixel to surpass Full HD resolution on screen.4 NFC requires use of a device that includes NFC and may require additional software.5 The projector supports direct peer-to-peer wireless casting of local content from Miracast-enabled devices or via the Epson iProjection app. For best performance when using Epson iProjection, it is recommended that the projector and connecting devices be configured on a network, either through the Ethernet port on the projector or via a wireless connection. The Epson iProjection App does not support all files and formats. See for details. EPSON and PowerLite are registered trademarks and Epson iProjection is a trademark of Seiko Epson Corporation. Brighter Futures and PixAlign are registered trademarks of Epson America, Inc. Miracast® and Wi-Fi® is a registered trademark of Wi-Fi Alliance®. All other product and brand names are trademarks and/or registered trademarks of their respective companies. Epson disclaims any and all rights in these marks. Copyright 2025 Epson America, Inc. View original content to download multimedia: SOURCE Epson America, Inc. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
34 minutes ago
- Yahoo
Seraphim Awarded 'Top Performer' in Kiwa PVEL's 2025 PV Module Reliability Scorecard for Sixth Time
SHANGHAI, June 11, 2025 /PRNewswire/ -- Recently, Kiwa PV Evolution Labs (Kiwa PVEL), a globally recognized independent testing laboratory, released its 2025 PV Module Reliability Scorecard. Seraphim has again secured the 'Top Performer' title in Kiwa PVEL's 2025 PV Module Reliability Scorecard, marking the sixth time of achieving this prestigious industry accolade. Through its rigorous Product Qualification Program (PQP), Kiwa PVEL subjects PV modules to a series of demanding tests, including Thermal Cycling (TC600), Damp Heat (DH2000), Potential Induced Degradation (PID), Light Induced Degradation (LID) combined with Light and Elevated Temperature Induced Degradation (LETID), and PAN (Performance After Normalization) analysis. These comprehensive assessments evaluate the modules' reliability and performance across multiple dimensions. In this year's evaluation, Seraphim's Sable series TOPCon modules excelled across all testing parameters, once again demonstrating Seraphim's exceptional product quality and strong brand reputation. This recognition serves as a trusted benchmark for financiers, developers, and system operators, providing authoritative guidance for decision-making. Seraphim's demonstrated reliability ensures consistent power output and lower operational costs while enhancing project investment returns, thereby strengthening commercial viability and competitive edge in the global market. Tristan Erion-Lorico, Vice President of Kiwa PVEL, commented: "Seraphim modules' exceptional resilience under rigorous testing conditions sets a new benchmark for the industry. We are delighted to see Seraphim once again achieve 'Top Performer' status. Their relentless commitment to quality and reliability is helping to push the boundaries of PV technology across the industry." Mr. Polaris Li, Chairman of Seraphim, expressed his gratitude: "We are honored to receive the 'Top Performer' from Kiwa PVEL. This achievement is the common result of all team's dedication and the professional recognition from Kiwa PVEL. As a pioneer in the industry, we remain committed to advancing technological innovation and delivering high-quality solutions that drive sustainable value for our global clients. This award not only acknowledges our past efforts but also motivates us to keep moving forward. Seraphim will continue to advance our technology and enhance our product performance, delivering even more efficient and reliable PV modules for our customers worldwide." With 14 years of expertise in PV module manufacturing, Seraphim has remained committed to delivering superior quality. Moving forward, Seraphim will continue to build reliable module products for diverse applications through technological innovation, iterative R&D, and rigorous production processes—creating greater value for global customers and contributing to the global carbon neutrality goals. SOURCE Seraphim Energy Group Sign in to access your portfolio
Yahoo
34 minutes ago
- Yahoo
Quanex Building Products Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
Quanex Building Products Corporation (NYSE:NX) just released its second-quarter report and things are looking bullish. It was overall a positive result, with revenues beating expectations by 3.0% to hit US$452m. Quanex Building Products also reported a statutory profit of US$0.44, which was an impressive 54% above what the analysts had forecast. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Quanex Building Products after the latest results. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. Taking into account the latest results, the most recent consensus for Quanex Building Products from four analysts is for revenues of US$1.85b in 2025. If met, it would imply a meaningful 14% increase on its revenue over the past 12 months. Per-share earnings are expected to leap 323% to US$1.58. Yet prior to the latest earnings, the analysts had been anticipated revenues of US$1.85b and earnings per share (EPS) of US$1.48 in 2025. The analysts seems to have become more bullish on the business, judging by their new earnings per share estimates. See our latest analysis for Quanex Building Products The consensus price target was unchanged at US$33.75, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders. Fixating on a single price target can be unwise though, since the consensus target is effectively the average of analyst price targets. As a result, some investors like to look at the range of estimates to see if there are any diverging opinions on the company's valuation. The most optimistic Quanex Building Products analyst has a price target of US$38.00 per share, while the most pessimistic values it at US$28.00. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth. One way to get more context on these forecasts is to look at how they compare to both past performance, and how other companies in the same industry are performing. The analysts are definitely expecting Quanex Building Products' growth to accelerate, with the forecast 29% annualised growth to the end of 2025 ranking favourably alongside historical growth of 9.0% per annum over the past five years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to grow their revenue at 5.4% per year. It seems obvious that, while the growth outlook is brighter than the recent past, the analysts also expect Quanex Building Products to grow faster than the wider industry. The most important thing here is that the analysts upgraded their earnings per share estimates, suggesting that there has been a clear increase in optimism towards Quanex Building Products following these results. Fortunately, they also reconfirmed their revenue numbers, suggesting that it's tracking in line with expectations. Additionally, our data suggests that revenue is expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates. With that said, the long-term trajectory of the company's earnings is a lot more important than next year. At Simply Wall St, we have a full range of analyst estimates for Quanex Building Products going out to 2026, and you can see them free on our platform here.. Don't forget that there may still be risks. For instance, we've identified 4 warning signs for Quanex Building Products (2 can't be ignored) you should be aware of. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.